Oncolytic Viruses for Multiple Myeloma Therapy

Although recent treatment advances have improved outcomes for patients with multiple myeloma (MM), the disease frequently becomes refractory to current therapies. MM thus remains incurable for most patients and new therapies are urgently needed. Oncolytic viruses are a promising new class of therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Calton, Christine M., Kelly, Kevin R., Anwer, Faiz, Carew, Jennifer S., Nawrocki, Steffan T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025383/
https://www.ncbi.nlm.nih.gov/pubmed/29903988
http://dx.doi.org/10.3390/cancers10060198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025383/
https://www.ncbi.nlm.nih.gov/pubmed/29903988
http://dx.doi.org/10.3390/cancers10060198

Ejemplares similares